Open Opportunities

The Indiana Department of Health’s (IDOH’s) Division of Trauma and Injury Prevention has been provided funding to support quality improvement projects and the ongoing development of the statewide trauma system.  To aid in the implementation of trauma system projects, the Indiana Department of Health will fund the following strategies (per Senate Enrolled Act No. 4).  Applicants must implement projects that target at least one strategy but can address multiple strategies if appropriate.

Strategy 1: Trauma System Development
Strategy 2: Quality Improvement
Strategy 3: Trauma and Non-Trauma Center Engagement
Strategy 4: Injury Prevention Programming

This request for application (RFA) is designed for all interested entities wishing to submit proposals for trauma system development under the core strategies outlined above. Funding decisions for all proposals submitted under this program will be made following a review process by the respective Trauma Regional Advisory Council, Trauma Care Commission Subcommittee, and Indiana Trauma Care Commission (TCC).

Eligible applicants might include hospitals, hospital networks, first responder agencies, statewide organizations, and entities with previous experience leading quality improvement activities.  An entity may submit more than one proposal.  An entity may submit more than one proposal but should ensure coordination with their respective TRAC.  TRAC locations and contact information can be found using this link.

Applicants will be allocated a set dollar amount based on the project scope and potential impact to address outlined strategies and improve Indiana’s trauma system.

NOTE:  If your application is selected for funding, IDOH will work with you to create the ID numbers defined below that are requested in the application form. These numbers are necessary prior to the finalization of a contract with the State.  If you have these numbers already established, please include them in your application.

AOS (Auditor of State) Supplier ID: This number is created by the State Comptroller’s Office and is required for you to receive a contract, purchase order, or receive a payment from the State of Indiana.  It requires the following:
1. W-9 Form
2. Direct Deposit Form

Tax ID/EIN: An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number and is used to identify a business entity. The Internal Revenue Service (IRS) issues this number.

IDOA Bidder ID: IDOA Supplier Portal, a ten-digit number assigned to companies when they register to bid on solicitations for new state contracts without having to detail certain corporation specifics on each submitted bid. You must have an IDOA Bidder ID.  Register here

Research Project Development Teams (PDTs) are groups of experienced senior faculty located on each of the Indiana CTSI campuses who will connect you with resources, collaboration opportunities, and small (typically up to $15,000) awards for preliminary or additional data. Each PDT is designed around a common research theme.

There are biostatisticians and regulatory experts on each team, and other experts are added, as needed, to the team to when your application is discussed. You will have access to the expertise and knowledge you need all in one place.

The PDT application process is contingent on the stage of the project. You have selected the application process for pilot funding from the PDTs for a first time external submission. If you are seeking pilot funding prior to an external resubmission please use Research Project Development Teams (PDTs):  Project Revision

Research Project Development Teams (PDTs) are groups of experienced senior faculty located on each of the Indiana CTSI campuses who will connect you with resources, collaboration opportunities, and small amounts of pilot funding for preliminary or additional data.  Each PDT is designed around a common research theme.

There are biostatisticians and regulatory experts on each team, and other experts are added, as needed, to the team to when your application is discussed. You will have access to the expertise and knowledge you need all in one place.

Awards are typically up to $15,000.  The PDTs have the ability to approve funding within a $15 - $30K for IU projects only depending on the scientific merit and justification.

The PDT application process is contingent on the stage of the project. You have selected the application process for pilot funding from the PDTs for an external resubmission.  If you are seeking pilot funding prior a first time external submission please use Research Project Development Teams (PDTs):  Project Refinement.

Commercialization Project Development Teams (PDTs) are groups of experienced entrepreneurial faculty located on each of the Indiana CTSI campuses who will connect you with resources and collaboration opportunities to support commercialization of your technology.

There are commercialization office representatives and regulatory experts on each team, and other experts are added to the team as needed when your application is discussed. You will have access to the expertise and knowledge you need all in one place. Full-time faculty (i.e., tenure-track, research, and clinical faculty) at any campus of Indiana University, the University of Notre Dame, or Purdue University who have submitted all relevant invention disclosures to their university’s commercialization office are eligible for funding.

Awards are typically up to $15,000 although the commercialization PDTs have the ability to approve funding within a $15 - $30K range for IU projects only, depending on scientific merit.

The IU Simon Comprehensive Cancer Center is providing an opportunity to fund cancer focused PI-directed applications to the National Institutes of Health that have been reviewed once and missed the NIH pay line and have a high potential for obtaining external funding. The goal is to increase the cancer focused NIH funding base. Non-NCI targeted applications should have significant cancer relevance.

Investigators wishing to apply to this funding mechanism must first submit their project to the IU External Resubmission Grant opportunity for funding consideration. If the project is not funded at the University level, an investigator can submit the project to the Cancer Center’s Near-Miss initiative for funding consideration.

Investigators wishing to apply to this funding mechanism must first submit a draft cover letter (letter of intent) for approval by the Cancer Center’s Executive Committee before working with a Coordinator to submit a full application. Once approved, the link for submitting the online application will be sent.

Maximum allowable amount for R01, R42 and R44 grants is $50K with P01 and SPORE funding amounts evaluated on a case-by-case basis.

IU Simon Comprehensive Cancer Center, Office of Community Outreach and Engagement is inviting collaborative proposals for implementing evidence-based cancer related programs within the community. Proposals should address the cancer burden in Indiana. The program should include an evaluation component and priority will be given to projects targeting one of the major cancer burdens in Indiana, including lung, breast, colon, pancreas, prostate and cervical. We are particularly interested in initiatives that promote healthier behaviors linking to reducing cancer incidence and morbidity. Of particular interest are community-led programs that expand our reach and deepen our understanding of populations across Indiana. The project must be co-led by an Cancer Center faculty member and a community advocate or partner.

The duration of this funding is one year, and the budget should not exceed $15,000.

The IU Simon Comprehensive Cancer Center requests applications from trainees for pilot funding to support innovative research focused on cancer. The primary purpose of this funding opportunity is to provide training on proposal writing, grant review process, and, if funded, how to manage funds. Proposals may span cancer biology, early drug development, including target identification, new model systems development and all aspects of cancer prevention and control including population science and symptom management to name a few. Proposals that provide training in new technologies are strongly encouraged. This mechanism may not be used to support clinical trials.

A submission link will be sent to applicants once the NOI is approved.

Funding is for up to $10,000 for one year. 

The goal of the Developmental and Hyperactive Ras Tumor (DHART) SPORE program is to improve the diagnosis and management of tumors arising in persons with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes through basic, translational, and clinical research.

Two funding opportunities are available via this program: the Developmental Research Program (DRP) and the Career Enhancement Program (CEP).

Funding is available for up to three DRP projects AND up to three CEP projects each at $50,000 - $75,000. Awards will be for a 12-month period.

The Postdoc Challenge offers postdoctoral researchers at Indiana University, IU School of Medicine, IUI, Purdue University, and the University of Notre Dame valuable proposal writing and reviewing experience in areas related to translational research through the use of one or more of the Indiana CTSI-designated core facilities at any of the partner universities. This is a competitive opportunity for a $5,000 award in the form of an expense account for use of core facility services. Funding is to be used ONLY for services provided by the Indiana CTSI Designated core facilities. Indiana CTSI-designated core facilities are listed on the Indiana CTSI Cores website.

The overall objective of the Indiana Traumatic Spinal Cord & Brain Injury Research program is to foster and encourage research for the prevention, treatment and cure of spinal cord and traumatic brain injuries, including acute management, medical complications, rehabilitative techniques, and neuronal recovery.  Collaborations are encouraged between Indiana-based researchers as well as with researchers located outside the state of Indiana.   Salary support for collaborators outside of Indiana will be limited, however.

Maximum requested amount:

• Basic science proposals may request up to $80,000 per year for two years
• Clinical research proposals (i.e. involving human subjects, human biological samples, or data from human subjects) may request up to $100,000 per year for two years
• Early commercialization proposals targeting new technologies (i.e. diagnostic or therapeutic drugs / devices) may request up to $100,000 for one year

Priority will be given to:

• Researchers who are submitting revised applications from the 2021 RFA
• Junior investigators (within 5 years of their last training period at the time of submission)
• Researchers embarking on a new research direction
• Returning investigators whose prior awards have resulted in demonstrable movement along the translational spectrum (e.g. from in vitro to in vivo) and/or led to extramural research support
• Early commercialization research that is reasonably expected to lead to future funding (SBIR/STTR, private investment)

The Indiana Clinical and Translational Sciences Institute is requesting applications for K12 Early Career Investigator Clinical – Translational Science and Research proposals.

These awards are designed to provide promising early career faculty investigators with the opportunity to be mentored in research-intensive, multi-disciplinary settings toward the goal of developing careers in clinical - translational science and research. Emphasis of the Indiana CTSI K12 Early Career Investigator Awards in Clinical - Translational Science and Research are to move findings from basic laboratory and pre-clinical research toward the development of new treatment options or interventions or clinical trials to eventual dissemination or clinical implementation to studying population health outcomes and health metrics. The phases of translational research may not necessarily be linear and can jump steps depending on the research project and the starting point. The goal of the Indiana CTSI is to make awards at all these stages. It is important that the proposed clinical - translational research has clear applications to human disease and health outcomes.

For details and eligibility requirements, please see the links below for the full announcement and other supporting documents. Applicants should open and read all the links under “Files for Investigators” before starting a submission.

Interested applicants are strongly encouraged to send their current CV, proposed working title, and abstract to Aaron Zych (ajzych@iu.edu) for eligibility pre-screening no later than December 4, 2026. Please note that as the Indiana CTSI is predominately funded by the NIH we must adhere to the unified funding strategy as outlined on the NIH website.

This Executive Associate Dean for Research (EADR) sponsored program is intended to support large, collaborative, interdisciplinary grants including, but not limited to, program project grants (P01s), center grants (P30s, P50s, P60s), and cooperative agreements (U54s). The goal of this initiative is to bring together faculty of Indiana University School of Medicine (IUSM) to collaborate and develop novel concepts that advance the mission and research goals of IUSM. These funds must be used for experiments to generate data to support the grant application. Support for this program is dependent on the availability of funds from the EADR.

Please see RFA linked below for details.

Since 1975, IUSM has received research funding through gifts made possible from the Ralph W. and Grace M. Showalter Research Trust Fund. The areas of appropriate biomedical research, eligible for funding, are broad and described by the benefactors as “the type of medical research that is most likely to permanently benefit mankind.” Donor intent prohibits the use of Showalter Trust funds for research in psychiatry, sociology, or social studies.

Applications for funding from the Ralph W. and Grace M. Showalter Research Trust will be reviewed in two stages. An initial review by the IUSM Biomedical Research Committee (BRC) will select the most meritorious proposals for further discussion and ranking. The BRC will then provide a recommended ranking to the Showalter Trustees who conduct a second review. Final funding decisions are made by the Showalter Trustees.

Applications should have a maximum requested amount of $75,000.